Cytokine release syndrome

Immunotherapy

Lymphoblastic Leukemia

Gastroenterology

Cancer

Internal medicine

Leukemia

Bone marrow

Surgery

Acute lymphocytic leukemia

Chimeric antigen receptor

Medicine

New England Journal of Medicine

CD19-specific chimeric antigen receptor (CAR) T cells induce high rates of initial response among patients with relapsed B-cell acute lymphoblastic leukemia (ALL) and long-term remissions in a subgroup of patients.

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia